Offerings |
Jun. 26, 2025
USD ($)
shares
|
|---|---|
| Offering: 1 | |
| Offering: | |
| Fee Previously Paid | false |
| Rule 457(r) | true |
| Security Type | Debt |
| Security Class Title | $1,650,000,000 5.200% Guaranteed Notes due 2035 |
| Amount Registered | shares | 1,650,000,000 |
| Proposed Maximum Offering Price per Unit | 0.9964 |
| Maximum Aggregate Offering Price | $ 1,644,126,000.00 |
| Fee Rate | 0.01531% |
| Amount of Registration Fee | $ 251,715.69 |
| Offering Note | Final prospectus supplement. |
| Offering: 2 | |
| Offering: | |
| Fee Previously Paid | false |
| Rule 457(r) | true |
| Security Type | Debt |
| Security Class Title | $750,000,000 5.900% Guaranteed Notes due 2055 |
| Amount Registered | shares | 750,000,000 |
| Proposed Maximum Offering Price per Unit | 0.9973 |
| Maximum Aggregate Offering Price | $ 748,005,000.00 |
| Fee Rate | 0.01531% |
| Amount of Registration Fee | $ 114,519.57 |
| Offering Note | See footnote 1 above. |
| Offering: 3 | |
| Offering: | |
| Fee Previously Paid | false |
| Other Rule | true |
| Security Type | Other |
| Security Class Title | Guarantee of $1,650,000,000 5.200% Guaranteed Notes due 2055 |
| Fee Rate | 0.01531% |
| Amount of Registration Fee | $ 0.00 |
| Offering Note | See footnote 1 above. Takeda Pharmaceutical Company Limited will fully and unconditionally guarantee the notes listed above. No separate consideration will be received therefor. Pursuant to Rule 457(n) under the Securities Act of 1933, as amended, no separate fee is payable with respect to such guarantees. |
| Offering: 4 | |
| Offering: | |
| Fee Previously Paid | false |
| Other Rule | true |
| Security Type | Other |
| Security Class Title | Guarantee of $750,000,000 5.900% Guaranteed Notes due 2055 |
| Fee Rate | 0.01531% |
| Amount of Registration Fee | $ 0.00 |
| Offering Note | See footnotes 1 & 3 above. |